The APOL1 risk genotypes were originally identified in African Americans with FSGS and/or ESKD, and FSGS is usually thought to arise from podocyte dysfunction (Genovese et al., 2010; Reidy et al., 2018). This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.